


Healthcare News Roundup: Diagnostics
HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
HSMN NewsFeed - 22 Oct 2013
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
BioReference Laboratories, Inc. Sued by Myriad Genetics, Confident in Its Position
HSMN NewsFeed - 14 Oct 2013
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
Myriad's myPath(TM) Melanoma Test is Highly Effective in Verification Study
HSMN NewsFeed - 8 Oct 2013
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
MolecularHealth Continues to Grow Management Team with New Chief Commercial Officer
HSMN NewsFeed - 4 Oct 2013
MetaStat's MetaSite Breast(TM) Diagnostic Assay Predicts Metastasis in Breast Cancer Study
MetaStat's MetaSite Breast(TM) Diagnostic Assay Predicts Metastasis in Breast Cancer Study
HSMN NewsFeed - 1 Oct 2013
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
BioMarker Strategies Names Jerry Parrott President and Chief Executive Officer
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 18 Sep 2013
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
Atossa Genetics Signs Distribution Agreement With McKesson Medical-Surgical
HSMN NewsFeed - 17 Sep 2013
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System(TM)
HSMN NewsFeed - 13 Sep 2013
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
Aethlon Medical Announces Dr. Douglas Taylor as Chief Scientific Officer of Exosome Sciences, Inc.
HSMN NewsFeed - 10 Sep 2013
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
Metamark Announces Positive Results of ProMark(TM) Prostate Cancer Clinical Validation Study
HSMN NewsFeed - 6 Sep 2013
LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer
LipoScience Announces Appointment Of William Cromwell, M.D., As Chief Medical Officer
